Global Needle-Free Devices Technologies and Markets to 2023 with Profiles of 3M, AstraZeneca, Bristol-Myers Squibb, GSK, Medtronic, Merck Serono, & Teva Pharma

4/2, 4:51 PM (Source: GlobeNewswire)

Dublin, April 02, 2019 (GLOBE NEWSWIRE) -- The "Needle-Free Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.

Based on the product type, the global needle-free device market is segmented into Needle-free Injectors, Inhaler technologies, Transdermal patch technologies and Other novel technologies (e.g., microneedles and pen needles).

Based on the application, the global needle-free device market is segmented into Pain management, Vaccine delivery, Insulin delivery, and Pediatric drug delivery.

The report includes a list of marketed and pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing market growth. The market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the global needle-free device market, as well as the competition in the global needle-free device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes on the company profiles of major vendors including company overview, key product offerings, financial statistics, and other developments. The report also provides insights on the market share and upcoming regional demand for the needle-less technologies.

Some of the major market players discussed in the report are 3M, Antares Pharma AG, Medtronic, Novartis, and Teva Pharmaceuticals. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

The Report Includes:

  • 36 data tables and 34 additional tables
  • A detailed overview of the global markets for needle-free devices and technologies within the industry
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Country-specific data and analysis for the United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, South Korea, Middle East, and Africa
  • Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
  • Insight into various needle-free technologies that are used in drug delivery and their various application areas
  • A look at the government regulations that can affect the global needle-free devices market
  • Identification of the competitive landscape of the market with the leading market players, suppliers and pharmaceutical partners
  • Profiles of major vendor companies, including 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck Serono S.A., and Teva Pharmaceutical Industries Ltd.

Major drivers of the global needle-free device market are as follows:

  • Increasing incidence of needlestick injuries.
  • Growing cases of needle phobia.
  • Increasing demand for painless drug delivery.
  • Product innovations.
  • Increased prevalence of diabetes globally.
  • Increasing incidence of blood-borne diseases globally.
  • Public awareness of HIV/AIDS and the significance of needle-free devices in preventing HIV.

Key Topics Covered:

Chapter 1 Introduction

  • Study Background
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Drug Delivery Devices Structure of Human Skin

  • Epidermis
  • Dermis
  • Hypodermis
  • Overview of Drug Delivery Systems and Technologies
  • Needle-free Devices
  • Drug Delivery, by Technology
  • Sustained Release Drug Delivery
  • Prodrug
  • Implants and Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Drug Delivery Systems, by Route of Administration
  • Oral Drug Delivery
  • Injectable or Parental Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Oral Mucosal Drug Delivery
  • Rectal Drug Delivery
  • Ocular Drug Delivery
  • Transdermal Drug Delivery
  • Need for Better Methods of Drug Delivery
  • Areas of Ongoing Research

Chapter 4 Needle-free Technology and Drug Delivery Devices

  • Needle-free Drug Delivery Devices and Types
  • History of Needle-free Devices
  • Demand for Needle-free Devices
  • Advantages of Needle-free Technology

Chapter 5 Needle-free Device Market Dynamics

  • Market Drivers
  • Increasing Incidence of Needlestick Injuries
  • Growing Cases of Needle Phobia
  • Increasing Demand for Painless Drug Delivery
  • Product Innovations
  • Increased Prevalence of Diabetes Globally
  • Increasing Incidence of Blood-Borne Diseases Globally
  • Growing Cases of HIV/AIDS
  • Market Restraints
  • Comparative High Cost of Needle-free Technology
  • Alternatives Available for Drug Delivery
  • High R&D Investments
  • Market Competition
  • Short Product Life Cycle
  • Competitive Landscape

Chapter 6 Market Breakdown by Product Type

  • Introduction
  • Needle-free Injectors
  • Introduction
  • Historical Background
  • Clinical Need
  • Components
  • Mechanism of Action
  • Applications
  • Unmet Needs
  • Future Developments
  • Needle-free Injectors Market, by Region
  • Needle-free Injectors Types
  • Needle-free Injectors, by Medication
  • Needle-free Injectors, by Drug Delivery
  • Needle-free Injectors, by Source of Power
  • Needle-free Injectors, by Usage Type
  • Inhaler Technologies
  • Pulmonary Drug Delivery
  • Advantages and Disadvantages of Inhaler Technologies
  • Advances in Pulmonary Drug Delivery
  • Future Developments
  • Inhaler Technologies Market, by Region
  • Type of Inhalers
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Transdermal Patch Technologies
  • Transdermal Drug Delivery
  • Clinical Need
  • Historical Background
  • Types of Transdermal Patches
  • Components
  • Benefits of Transdermal Patches Over Other Dosage Forms
  • New Innovations in Transdermal Patches
  • Clinical Issues of Transdermal Delivery
  • Future Developments
  • Transdermal Patch Technologies Market, by Region
  • Other Novel Technologies
  • Microneedles
  • Pen Needles

Chapter 7 Market Breakdown by Application

  • Application of Needle-free Devices
  • Pain Management
  • Vaccine Delivery
  • Insulin Delivery
  • Pediatric Drug Delivery

Chapter 8 Market Breakdown by Region

  • Introduction
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • South America
  • Middle East and Africa

Chapter 9 Market Strategy

  • Market Strategy
  • Key Mergers and Acquisitions
  • Exclusive Partnership Announced by PharmaJet and Mundipharma
  • Aequus and Corium Jointly Collaborate for Transdermal Patches
  • United Therapeutics Corp. Entered into Licensing Agreement
  • Takeda Pharmaceutical Company and Portal Instruments Entered into Collaboration
  • Medherant Signed an Agreement with a Japanese Company
  • 3M Drug Delivery System Announced Collaboration with Panacea Pharmaceutical
  • Cipla and MannKind Corp. Entered into Collaboration
  • Increasing Adoption of Home Healthcare Concept
  • Key Product and Technology Developments
  • Hind Syringes Developed Disposable Pen Needle
  • BD Introduced New Pen Needle
  • Development of Innovative Transdermal Patch Technology
  • Introduction of Smart Inhalers
  • Vaxxas' Nanopatch Garners WHO Support for Polio Vaccine Delivery

Chapter 10 Marketed and Pipeline Products

  • Key Marketed Products
  • Needle-free Injectors
  • Inhalers
  • Transdermal Patch
  • Other Novel Needle Technologies
  • Pipeline Products
  • Needle-free Injectors
  • Metered Dose Inhalers
  • Transdermal Patches

Chapter 11 Regulatory Structure

  • Regional Regulatory Structures
  • United States
  • European Union
  • Japan
  • China
  • Hong Kong
  • Korea
  • Taiwan
  • India
  • FDA Technical Considerations
  • FDA Recall and Safety Alerts
  • Occupational Health and Safety Laws

Chapter 12 Reimbursement and Pricing

  • Regional Reimbursement Structure
  • United States
  • Europe
  • Japan
  • Rest of Asia-Pacific
  • Pricing Trends

Chapter 13 Conclusions and Outlook for Needle-free Devices

  • Major Market Influencers
  • Social Factors
  • Technological Developments
  • Demographic and Economic Trends
  • Transformations in the Healthcare Industry
  • Future Outlook

Chapter 14 Company Profiles

  • 3M
  • Activa Brand Products, Inc.
  • Akra Dermojet
  • Alkermes Plc
  • Amnio Technology Llc.
  • Antares Pharma, Inc.
  • Aradigm Corp.
  • Astellas Pharma, Inc.
  • Astrazeneca Plc
  • Battelle
  • Bespak Europe Ltd.
  • Bioject Medical Technologies
  • Bristol-Myers Squibb
  • Clearside Biomedical, Inc.
  • Corium International, Inc.
  • Crossject
  • Captisol
  • D'antonio Consultants International
  • Duoject Medical Systems, Inc.
  • Durect Corp.
  • Echo Therapeutics
  • Endo International
  • Ferndale Pharma Group, Inc.
  • Ferring Pharmaceuticals, Inc.
  • Gerresheimer Ag
  • Glaxosmithkline Plc
  • Glide Pharmaceutical Technologies Ltd.
  • Haselmeier Gmbh
  • Injex Pharma Ag
  • JCR Pharmaceuticals Co. Ltd.
  • Keystone Industries
  • Lineage Therapeutics, Inc.
  • Lohmann Therapie-Systeme Ag
  • Medical International Technologies
  • Medtronic
  • Merck Serono S.A.
  • Minnesota Rubber & Plastics
  • Mylan, Inc.
  • Nanopass Technologies Ltd.
  • National Medical Products, Inc.
  • Novartis
  • Noven Pharmaceuticals
  • Novo Nordisk A/S
  • Nypro, Inc.
  • Penjet Corp.
  • Syneron Medical Ltd.
  • Team Consulting Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Theraject, Inc.
  • Valeritas, Inc.
  • Vaxxas Pty Ltd.
  • Ypsomed Ag
  • Zogenix, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/v7krc6/global?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables , Needles and Syringes 

22157.jpg

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.